Seronegative Sjögren Syndrome: A Forgotten Entity?

Area of Science:

• Rheumatology
• Immunology
• Autoimmune Diseases

Background:

• Sjögren syndrome (SS), also known as Sjögren disease, is a systemic autoimmune disorder.
• Prevalence estimates range from 0.01% to 0.72% of the global population.
• SS disproportionately affects females, highlighting a significant gender bias in its epidemiology.

Discussion:

• The multifaceted nature of Sjögren syndrome presents diagnostic and therapeutic challenges.
• SS imposes a substantial burden on patients' quality of life.
• Impaired physical function is a common consequence for individuals with SS.

Key Insights:

• Understanding the variability of Sjögren syndrome is crucial for effective management.
• The significant impact on quality of life underscores the need for comprehensive patient support.
• Addressing the functional limitations associated with SS is a key aspect of patient care.

Outlook:

• Further research into the pathogenesis of SS may reveal novel therapeutic targets.
• Improving diagnostic criteria and early detection can mitigate long-term complications.
• Enhancing multidisciplinary care approaches will optimize outcomes for Sjögren syndrome patients.